These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26722419)

  • 1. Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis.
    Wang Y; Pei F; Wang X; Sun Z; Hu C; Dou H
    Int J Clin Exp Pathol; 2015; 8(10):12319-32. PubMed ID: 26722419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis.
    Dai C; Jiang M; Sun MJ; Cao Q
    J Clin Gastroenterol; 2020 Jul; 54(6):545-553. PubMed ID: 30994521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: a diagnostic meta-analysis.
    Zhou XL; Xu W; Tang XX; Luo LS; Tu JF; Zhang CJ; Xu X; Wu QD; Pan WS
    BMC Gastroenterol; 2014 Jul; 14():121. PubMed ID: 25002150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: A systematic review and meta-analysis.
    Dai C; Jiang M; Sun MJ; Cao Q
    J Gastroenterol Hepatol; 2018 May; 33(5):990-997. PubMed ID: 29427297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.
    Mosli MH; Zou G; Garg SK; Feagan SG; MacDonald JK; Chande N; Sandborn WJ; Feagan BG
    Am J Gastroenterol; 2015 Jun; 110(6):802-19; quiz 820. PubMed ID: 25964225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea.
    Fine KD; Ogunji F; George J; Niehaus MD; Guerrant RL
    Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.
    Gisbert JP; Bermejo F; Pérez-Calle JL; Taxonera C; Vera I; McNicholl AG; Algaba A; López P; López-Palacios N; Calvo M; González-Lama Y; Carneros JA; Velasco M; Maté J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1190-8. PubMed ID: 19291780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
    Rokkas T; Portincasa P; Koutroubakis IE
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):299-306. PubMed ID: 30240474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity.
    Lin JF; Chen JM; Zuo JH; Yu A; Xiao ZJ; Deng FH; Nie B; Jiang B
    Inflamm Bowel Dis; 2014 Aug; 20(8):1407-15. PubMed ID: 24983982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy.
    Bar-Gil Shitrit A; Koslowsky B; Livovsky DM; Shitrit D; Paz K; Adar T; Adler SN; Goldin E
    Scand J Gastroenterol; 2017 Mar; 52(3):328-333. PubMed ID: 27841040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.
    Mao R; Xiao YL; Gao X; Chen BL; He Y; Yang L; Hu PJ; Chen MH
    Inflamm Bowel Dis; 2012 Oct; 18(10):1894-9. PubMed ID: 22238138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activity.
    Klimczak K; Lykowska-Szuber L; Eder P; Krela-Kazmierczak I; Stawczyk-Eder K; Szymczak A; Michalak M; Studniarek A; Linke K
    Eur J Intern Med; 2015 Oct; 26(8):623-7. PubMed ID: 26198785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
    Jusué V; Chaparro M; Gisbert JP
    Dig Liver Dis; 2018 Apr; 50(4):353-359. PubMed ID: 29396129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between fecal lactoferrin and inflammatory bowel disease.
    Dai J; Liu WZ; Zhao YP; Hu YB; Ge ZZ
    Scand J Gastroenterol; 2007 Dec; 42(12):1440-4. PubMed ID: 17852860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease.
    Kopylov U; Rosenfeld G; Bressler B; Seidman E
    Inflamm Bowel Dis; 2014 Apr; 20(4):742-56. PubMed ID: 24562174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG; Gomollon F
    Inflamm Bowel Dis; 2009 Nov; 15(11):1746-54. PubMed ID: 19363798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal lactoferrin, a marker of intestinal inflammation in children with inflammatory bowel disease.
    Borkowska A; Liberek A; Łuczak G; Jankowska A; Plata-Nazar K; Korzon M; Kamińska B
    Acta Biochim Pol; 2015; 62(3):541-5. PubMed ID: 26339799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease.
    Jayasooriya N; Baillie S; Blackwell J; Bottle A; Petersen I; Creese H; Saxena S; Pollok RC;
    Aliment Pharmacol Ther; 2023 Mar; 57(6):635-652. PubMed ID: 36627691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fecal neutrophil gelatinase-associated lipocalin is a surrogate marker of inflammation in inflammatory bowel disease].
    Zinkevich OD; Mukhametova DD; Abdulganieva DI; Safina NA; Koporulina MO; Odintsova AKh
    Eksp Klin Gastroenterol; 2014; (10):22-7. PubMed ID: 25911926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.